RB homepage

Andrew Einstein, MD, PhD, FACC, MASNC, MSCCT, FSCMR, incoming 2027 president of the American Society of Nuclear Cardiology (ASNC), professor of medicine in radiology, and director of nuclear cardiology, cardiac CT and cardiac MRI at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, discusses the potential and limitations of using coronary CT angiography (CCTA) as a screening modality. He also discusses the role of opportunistic imaging.

Andrew Einstein, MD, PhD, spoke to Cardiovascular Business about the potential benefits and limitations of using coronary CT angiography as a screening modality.

An Illinois appellate judge upheld a pervious trial victory that cleared and central Illinois cardiologist Amit Dande, MD, and Prairie Cardiovascular Consults LLP of alleged misdiagnosis of the severity of a patient's heart condition that led to his death prior to a schedule percutaneous coronary intervention (PCI).

Heartflow filed the lawsuit after Elucid received FDA clearance for its new AI-enabled FFR-CT software. Elucid, meanwhile, is standing behind its technology and plans on responding through the appropriate legal channels.

"Particularly strong" performance among women in their 70s signals the importance of continuing screening into later ages, experts write in RSNA's Radiology: Imaging Cancer. 

University of Arkansas for Medical Sciences UAMS lung screening mobile unit

With the help of a $4M appropriation from HHS, the UAMS Winthrop P. Rockefeller Cancer Institute is rolling out 2 of 3 new state-of-the-art mobile lung screening coaches, with the third following soon. 

Amid expanding use of image-guided therapies in oncology, interventional radiology experts are calling for action to address this issue.

UW-Madison is adding to its radionuclide research and production facilities, including the nation’s first cyclotron dedicated to producing alpha-particle-emitting radionuclides.